Sol-Gel Share Price

Sol-Gel Share Price

NASDAQ: SLGL | Healthcare
$53.67
+$2.95 (5.82%) Last updated on 19 Nov, 2026 | 01:19 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Sol-Gel Stock Performance

Open
N/A
Prev. Close
$50.72
Circuit Range
N/A
Day Range
N/A
Year Range
$36.61 - $90.00
Volume
N/A
Average Traded
N/A

Sol-Gel Share Price Chart

Line chart of the Sol-Gel price trend over the selected period. The price rose overall, ranging from 52.47 to 54.89, ending at 53.67.
$0.00$0.00
L
Show Current Price
H

Sol-Gel Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$19.39B
Return On Equity (TTM)
N/A
Profit Margin
-31.61%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Sol-Gel Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$3.88$1.55$11.54$19.39
Net Profit-$14.92-$27.24-$10.58-$6.13
Net Profit Margin-384.54%-1757.42%-91.68%-31.61%
Income ChangeN/A-82.57%61.16%42.06%

Sol-Gel Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets2.954.554.123.57
Current Assets26.9731.341.1743.06
Total Assets29.9235.8545.2946.63
Non Current Liabilities0.941.712.121.09
Current Liabilities6.175.294.523.33
Total Liabilities7.117.06.644.42
Shareholders' Equity22.8128.8538.6442.21

Sol-Gel Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating0.32-13.89-17.73-9.48
Investing-8.5826.69-9.741.7
Financing0.010.021.810.02

Corporate Actions

Split
Ex-date: 05 May 2025

About Sol-Gel

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Sol-Gel Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$66.62
$50.72
-26.02%
Oct 2026
$70.75
$68.56
-9.20%
Sep 2026
$70.42
$75.50
+2.22%
Aug 2026
$82.85
$73.86
-11.52%
Jul 2026
$72.81
$83.48
+10.06%
Jun 2026
$70.71
$75.85
-4.09%
May 2026
$75.31
$79.08
+15.88%
Apr 2026
$82.50
$68.25
-13.93%
Mar 2026
$89.64
$79.30
-11.89%
Feb 2026
$62.50
$90.00
+43.54%
Jan 2026
$43.65
$62.70
+49.96%
Dec 2025
$36.95
$41.81
+6.13%

Sol-Gel Share Price FAQs